> ## Documentation Index
> Fetch the complete documentation index at: https://docs.medstrato.com/llms.txt
> Use this file to discover all available pages before exploring further.
# KOL Tiering: A Practical Framework for Medical Device Companies
> Learn how to classify Key Opinion Leaders into strategic tiers based on influence, expertise, and engagement potential using a proven 4-tier framework.
## Why Tiering Matters
Not all KOLs are equal. A global thought leader who chairs international conferences requires different engagement than an emerging researcher. Tiering helps you:
* **Allocate resources effectively**: Focus time and budget on highest-impact relationships
* **Customize engagement strategies**: Different tiers need different touchpoints
* **Measure portfolio health**: Ensure balanced coverage across influence levels
* **Align cross-functional teams**: Give everyone a common language for prioritization
## The 4-Tier Framework
| Tier | Definition | Typical Profile | Engagement Strategy |
| ---------- | ---------------------- | --------------------------------------------------------------------------------- | ----------------------------------------------------------------------- |
| **Tier 1** | Global thought leaders | Top journal authors, international conference chairs, guideline committee members | 1:1 strategic partnership, personal relationship with senior leadership |
| **Tier 2** | Regional experts | National society board members, active researchers, frequent speakers | Advisory boards, speaker programs, investigator meetings |
| **Tier 3** | Local influencers | Hospital department heads, high-volume practitioners, regional opinion shapers | Educational events, peer-to-peer programs, local symposiums |
| **Tier 4** | Emerging voices | Early-career researchers, rising clinicians, digital-native physicians | Content engagement, early access programs, mentorship opportunities |
## Tiering Criteria
Use these factors to classify KOLs:
### 1. Scientific Influence
| Factor | How to Assess | Data Sources |
| --------------------- | ----------------------------------------------- | ------------------------------------- |
| Publication record | H-index, citation count, journal impact factors | PubMed, Google Scholar |
| Guideline involvement | Authorship on clinical guidelines | Society websites, guideline documents |
| Grant funding | PI on major research grants | NIH Reporter, institutional profiles |
| Patent activity | Inventor on relevant patents | USPTO, patent databases |
### 2. Clinical Influence
| Factor | How to Assess | Data Sources |
| ----------------- | ------------------------------------------ | ------------------------------- |
| Procedure volume | Number of relevant procedures performed | Hospital data, claims databases |
| Referral network | Physicians who refer patients to this KOL | Network analysis tools |
| Training role | Fellowship director, residency faculty | Institutional websites |
| Adoption behavior | Early vs. late adopter of new technologies | Field intelligence, sales data |
### 3. Professional Influence
| Factor | How to Assess | Data Sources |
| ------------------- | --------------------------------------- | -------------------------------------- |
| Society leadership | Board positions, committee chairs | Society websites |
| Conference presence | Speaking roles, session chairs | Conference programs |
| Media presence | Quoted in press, social media following | News searches, social platforms |
| Peer recognition | Awards, named lectures | CV review, institutional announcements |
### 4. Engagement Potential
| Factor | How to Assess | Data Sources |
| ------------------------ | ------------------------------- | ---------------------------------------- |
| Past collaboration | History with your company | CRM records, MedStrato activity log |
| Competitor relationships | Engagements with competitors | Field intelligence, disclosure databases |
| Availability | Willingness to participate | Direct outreach, response history |
| Alignment | Fit with your therapeutic focus | Research interests, clinical practice |
## How to Apply This in MedStrato
### Step 1: Create Tiering Criteria for Your Context
Customize the framework for your therapeutic area:
**Example: Structural Heart Devices**
* Tier 1: Performing 100+ TAVR procedures/year, guideline author, international speaker
* Tier 2: Performing 50-100 procedures/year, national speaker, active researcher
* Tier 3: Performing 20-50 procedures/year, regional influence
* Tier 4: Early career, fewer than 20 procedures/year, digital presence
### Step 2: Assess and Classify KOLs
1. Go to **KOL** in MedStrato
2. Open a KOL profile
3. Review available data:
* Publications count and H-index (if available)
* Specialties and expertise areas
* Past event participation
* Engagement history
4. Set the **Tier** field: Tier 1, Tier 2, or Tier 3
5. Set the **Engagement Level**: High, Medium, or Low
Tier reflects *potential* influence. Engagement Level reflects *current* relationship status. A Tier 1 KOL might have Low engagement if you haven't worked with them yet.
### Step 3: Use Tiers for Planning
**Filter by Tier** in the KOL list to:
* Plan advisory board composition (mix of Tier 1-2)
* Identify Tier 3 KOLs for regional speaker programs
* Find Tier 4 KOLs for early career development initiatives
**Use AI Insights** to:
* Get product alignment recommendations per tier
* Identify event opportunities for specific KOLs
* Suggest engagement strategies
### Step 4: Review and Update Regularly
KOL status changes over time. Review tiering:
* **Annually**: Full portfolio review
* **Quarterly**: Spot-check top KOLs for changes
* **Event-driven**: Update after major publications, role changes, or collaborations
## Common Tiering Mistakes
| Mistake | Why It's a Problem | How to Avoid |
| --------------------------------- | -------------------------------------------------------------------- | -------------------------------------------------- |
| **Over-weighting publications** | Clinician KOLs may have fewer publications but high procedure volume | Balance scientific and clinical criteria |
| **Static tiering** | KOLs rise and decline in influence | Schedule regular reviews |
| **Ignoring engagement potential** | High-influence KOL who won't engage is less valuable | Include availability and alignment factors |
| **Too many Tier 1s** | Dilutes focus and resources | Limit Tier 1 to top 5-10% of your database |
| **Subjective classification** | Different team members classify differently | Document criteria, train team, calibrate regularly |
## Portfolio Health Metrics
Track these metrics across your KOL database:
| Metric | Target | Why It Matters |
| ------------------- | ---------------------------------------------- | --------------------------------- |
| Tier distribution | 10% Tier 1, 25% Tier 2, 40% Tier 3, 25% Tier 4 | Ensure balanced portfolio |
| Engagement coverage | 80%+ of Tier 1-2 with recent activity | High-value KOLs should be engaged |
| Tier mobility | 5-10% tier changes per year | Shows portfolio is dynamic |
| Geographic coverage | Aligned with market priorities | Ensure regional representation |
## Template: Tiering Scorecard
Use this template to standardize tiering decisions:
| Criterion | Weight | Score (1-5) | Weighted Score |
| -------------------- | ------ | ----------- | -------------- |
| Publication impact | 20% | | |
| Clinical volume | 25% | | |
| Society leadership | 20% | | |
| Conference presence | 15% | | |
| Engagement potential | 20% | | |
| **Total** | 100% | | |
**Scoring guide:**
* Score 4.0+: Tier 1
* Score 3.0-3.9: Tier 2
* Score 2.0-2.9: Tier 3
* Score below 2.0: Tier 4
## Related Resources
Complete guide to managing KOLs in MedStrato.
End-to-end workflow from discovery to relationship.